Looking At Moderna's Recent Unusual Options Activity
Portfolio Pulse from Benzinga Insights
A significant investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 58% of recent trades being bearish and 41% bullish. The majority of these trades are puts, with a total amount of $1,041,280, compared to calls amounting to $119,205. The targeted price range for Moderna over the last 3 months has been between $60.0 and $175.0. The current price of MRNA is down -1.64% at $99.54, and RSI indicators suggest the stock may be oversold.
August 08, 2023 | 4:00 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
A significant investor has taken a bearish stance on Moderna, with the majority of trades being puts. The targeted price range for Moderna over the last 3 months has been between $60.0 and $175.0.
The bearish stance taken by a significant investor, coupled with the majority of trades being puts, indicates a negative outlook for Moderna. This could potentially lead to a decrease in the stock's price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100